基因组景观和分子知情疗法用于胸膜癌和其他高级胸膜上皮瘤

Lino Möhrmann1, Lysann Rostock2, Maximilian Werner3

  • 1Computational Health Informatics Program, Boston Children's Hospital, Harvard Medical School, Boston, USA; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT), NCT Dresden, a partnership between DKFZ, Faculty of Medicine and University Hospital Carl Gustav Carus, TUD Dresden University of Technology, and Helmholtz-Zentrum Dresden-Rossendorf (HZDR), Germany; Translational Medical Oncology, Faculty of Medicine, and University Hospital Carl Gustav Carus, TU Dresden University of Technology, Dresden, Germany; German Cancer Consortium (DKTK), Dresden, Germany.

Med (New York, N.Y.)
|March 19, 2025
PubMed
概括

这项研究揭示了胸膜上皮瘤 (TETs) 中明显的分子特征,确定了影响生存的胸膜癌 (TCs) 中的"热"和"冷"亚型. 精确瘤学改善了结果,特别是对于TC患者.

相关概念视频

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.5K